ArticleInternational journal of genomics2025

CLDN22 Serves as a Novel Prognostic Biomarker and Immunotherapy Response Predictor in Gliomas: A Comprehensive Multiomics Analysis.

Hui Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.